HYFT

MindWalk Holdings Corp.

Healthcare · Biotechnology

$155.51 sample

+1.92 (+1.25%) 1D

Market cap

$383.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-23

Alerts

8

Price$155.51 +2.24% 3M daily closessample

158.76148.45

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Chief Executive Officer
Sep 23SEC10-Q filed
Sep 16INSInsider buy: EVP, Operations
Sep 10SEC10-Q filed
Sep 03INSInsider buy: General Counsel
Aug 28SEC10-Q filed
Aug 25INSInsider buy: General Counsel
Aug 18SEC8-K filed: material event

Sign up to see the real HYFT record →

Company facts

SEC EDGAR registration

Name: MindWalk Holdings Corp.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +38sample, -100 to +100
Reporting currency: USD

Who is positioning in HYFT

sample

Insiders: 27 insider transactions over 90 days, net selling, $843.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 7 funds hold $4.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.7B +13.7% y/y

Q4 2024Q3 2026

Inventory$9.3B +12.7% y/y

Q4 2024Q3 2026

Accounts receivable$6.7B +6.1% y/y

Q4 2024Q3 2026

Total debt$18.0B +5.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $76.2B -1.3% 3M
Sample peer B: $167.1B +14.6% 3M
Sample peer C: $233.1B +7.4% 3M
Sample peer D: $89.2B -0.5% 3M
Sample peer E: $378.5B +0.9% 3M